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Highlights 
• Ubiquinone is a crucial component of bacterial bioenergetics  
• The bacterial pathways to produce ubiquinone are highly diverse 
• Ubiquinone is produced in anoxic conditions by a dioxygen-independent pathway 
• Ubi-, mena- and plasto-quinone biosynthetic pathways are evolutionary related  
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Abstract 
 Ubiquinone is an important component of the electron transfer chains in proteobacteria and 
eukaryotes. The biosynthesis of ubiquinone requires multiple steps, most of which are common to bacteria 
and eukaryotes. Whereas the enzymes of the mitochondrial pathway that produces ubiquinone are highly 
similar across eukaryotes, recent results point to a rather high diversity of pathways in bacteria. This review 
focuses on ubiquinone in bacteria, highlighting newly discovered functions and detailing the proteins that 
are known to participate to its biosynthetic pathways. Novel results showing that ubiquinone can be 
produced by a pathway independent of dioxygen suggest that ubiquinone may participate to anaerobiosis, 
in addition to its well established role for aerobiosis. We also discuss the supramolecular organization of 
ubiquinone biosynthesis proteins and we summarize the current understanding of the evolution of the 
ubiquinone pathways relative to those of other isoprenoid quinones like menaquinone and plastoquinone.  
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1) Introduction 
Isoprenoid quinones are central to bioenergetics as they constitute obligate electrons and protons 
shuttles in the respiratory chains of most organisms. These molecules are composed of a quinone head 
group (in most cases a naphto- or a benzo- ring) to which is attached a polyprenyl tail with a length that 
varies depending on the organisms (from 4 to 14 isoprene units, indicated as subscript, Q4-14) 1. A specific 
number of isoprene units characterizes the quinone pool (Qn) of a given species, but several lower 
abundance isoprenologs, typically Qn-1 and Qn+1, are also usually produced 2,3.  The polyprenyl tail is 
hydrophobic and localizes isoprenoid quinones inside membranes. The polar head group is the functional 
part of the molecule and undergoes a two-steps redox chemistry between quinone (oxidized) and quinol 
(reduced) forms 1. Historically, isoprenoid quinones have been used as chemotaxonomic markers 2,3 and 
more recently, quinone profiles served as markers of bacterial communities in complex ecosystems 4,5.  
Isoprenoid quinones are classified based on the nature of the head group and also according to 
their midpoint redox potential. Menaquinone (MK) belongs to naphtoquinones, whereas ubiquinone (UQ), 
plastoquinone (PQ) and rhodoquinone (RQ) are benzoquinones. Classically, MK and RQ are considered low 
potential quinones (E’  -70 mV), whereas UQ and PQ are high potential quinones (E’  +100 mV) 6. The 
redox potential of quinones determines the protein partners with which they functionally interact in 
respiratory chains. Excellent reviews have covered the taxonomic distribution, the functions and the 
biosynthesis of isoprenoid quinones 1,7 and the case of RQ is discussed in details by Shepherd and 
colleagues in this issue of BBA-Bioenergetics 8.  
MK, which is present in most bacterial phyla and in archaea, was proposed to have been a 
component of the bioenergetic toolbox of the last universal common ancestor (LUCA) 6,9. In contrast, UQ 
evolved later and is restricted to specific classes of proteobacteria (, , ) and to eukaryotes, in which UQ 
participates to oxidative phosphorylation in mitochondria. Much attention has been paid to the 
biosynthesis and functions of UQ (also called coenzyme Q) in eukaryotes, and these topics - including the 
pathologies resulting from coenzyme Q deficiencies in humans - have been covered recently in 
authoritative reviews 7,10–13.  
In contrast, an update is needed for UQ in bacteria. The historical model to study bacterial UQ 
biosynthesis has been Escherichia coli and several recent discoveries advanced our understanding of the 
UQ pathway in this species. At the same time, studies on other bacterial models revealed substantial 
differences with the E. coli pathway and highlighted an unsuspected diversity of solutions evolved by 
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bacteria to synthesize UQ. The numerous sequences of bacterial genomes now available in public 
databases also appear to be a very relevant source of information with this respect. In this review, we 
summarize the recent results obtained on bacterial UQ biosynthesis and functions, and we emphasize how 
they advanced our current understanding of the field.  
 
2) New functions for UQ in bacteria  
The functions of UQ related to respiration, gene regulation and oxidative stress have been 
reviewed elsewhere 14,15 and will not be covered here. In 2014, Sevin and Sauer reported that UQ promotes 
tolerance to osmotic stress in E. coli 16. The authors showed that the growth of a UQ-deficient strain was 
impaired when the medium contained high concentrations of salt. Furthermore, they observed a 100 
fold increase of the UQ content in response to osmotic stress 16. In such conditions, UQ represented 1% 
of the lipids constituting the plasma membrane of E. coli. UQ and structural analogs had a stabilizing effect 
on liposomes, which led the authors to propose that the polyprenyl tail of UQ mediates a mechanical 
stabilization of the plasma membrane that likely explains the osmoprotective effect observed in vivo 16. 
However, these results have been challenged recently 17. Indeed, a new study suggests that the impaired 
growth of UQ-deficient E. coli cells at high osmotic pressure was simply caused by the compromised 
function of the respiratory chain, which affected the proton-solute symporter ProP 17. ProP mediates the 
uptake of zwitterionic osmolytes such as proline and glycine betaine, and requires high proton-motive 
force for function. As the proton gradient is compromised in the absence of UQ, the function of ProP is 
impaired, impacting osmotic regulation 17. The authors also found that UQ amounted to 1% of the total 
lipids, but the UQ content was not significantly modulated by the osmotic pressure of the growth medium 
17, consistent with unpublished results from several laboratories (personal communications of David 
Pagliarini and Gilles Basset) and ours. Overall, it appears that UQ levels do not respond to osmotic stress 
and that the decreased tolerance to osmotic stress observed in UQ-deficient E. coli cells results from an 
indirect effect of the inactivation of the respiratory chain 17. Even though multiple in vitro studies reported 
that UQ modifies the mechanical and physical properties of liposomes (16,18 and references therein), 
sometimes at UQ contents hardly compatible with biological levels, the direct impact of UQ on the 
properties of membranes does not seem relevant for protection against osmotic stress in vivo.    
A new contribution of UQ to cell metabolism was described by Chaba and colleagues who showed 
that UQ is required by E. coli to grow on medium containing long-chain fatty acids (LCFAs) as a carbon 
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source 19. Interestingly, mutants with intermediate UQ levels (15-20% compared to wild-type) grew 
normally on various non-fermentable carbon sources but not on the LCFA oleate. Thus, in addition to its 
role as an electron shuttle in the respiratory chain, UQ has another function in oleate metabolism. The 
authors suggested that the antioxidant function of the reduced form of UQ was important based on the 
observations that the level of reactive oxygen species (ROS) increased in cells metabolizing oleate, and 
that supplementation with antioxidants improved growth and decreased ROS levels of UQ-deficient 
mutants in oleate-containing medium 19. Remarkably, UQ levels increased 1.8 fold in cells metabolizing 
oleate. Overall, the authors proposed that UQ is the preponderant antioxidant system during LCFA 
degradation and acts to mitigate ROS production by the acyl-CoA dehydrogenase FadE. In this regard, UQ 
might be particularly important for pathogenic bacteria that use LCFAs derived from host tissues as their 
main nutrient 19. 
 
3) UQ biosynthesis in E. coli 
3.1  Biochemical steps of the classical pathway and enzymes involved  
Over a period of several decades, the UQ biosynthetic pathway has been extensively studied in E. 
coli, a bacterium that synthesizes UQ8 as its main isoprenolog. Nowadays, the pathway is known to require 
twelve proteins (UbiA to UbiK and UbiX), most of them being involved in reactions that modify the 
aromatic ring originating from 4-hydroxybenzoic acid (4-HB) (Figure 1). UbiC is the first committed enzyme 
in the biosynthesis of UQ8, catalyzing the removal of pyruvate from chorismate to produce 4-HB 20. Then, 
the membrane-bound UbiA prenylates 4-HB using octaprenyl diphosphate as a side chain precursor 21. 
Recent three dimensional (3D) structures of two members in the UbiA superfamily 22,23 revealed an all α-
helical structure that is completely different from the α/β barrel structure of soluble aromatic 
prenyltransferases, in agreement with a catalysis that occurs in lipid bilayers. Both UbiA homologs contain 
nine transmembrane helices arranged counterclockwise in a U-shape presenting a large central cavity with 
an opening assimilated to a lateral portal that is largely buried in the membrane. It was proposed that this 
lateral portal may facilitate the binding of long-chain isoprenyl diphosphate substrates, the prenylated 
products being directly released into membranes through this portal 22,23.  We note that the two 
crystallized UbiA homologs belong to archaeal species and as such do not participate to UQ biosynthesis. 
However, given the conservation of important catalytic residues with E. coli UbiA 23, we believe that the 
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structural insights provided by these structures are largely applicable to UbiA family members involved in  
UQ biosynthesis.  
 
Figure 1: Model of UQ8 biosynthesis in E. coli and supramolecular organization of the pathway. The names 
of precursors and intermediates are indicated in blue. The red dotted rectangle delimits the Ubi-complex, 
which is composed of UbiE to UbiK proteins and encompasses the last six reactions of the pathway. The 
numbering of the aromatic carbon atoms is shown on OPP. Abbreviations used are: 4-HB, 4-
hydroxybenzoate; OHB, octaprenyl-4-hydroxybenzoate; OPP, octaprenyl phenol; DDMQ8, C2-demethyl-
C6-demethoxy-ubiquinone 8; DMQ8, C6-demethoxy-ubiquinone 8; UQ8, ubiquinone 8. The 3D-structures 
of UbiC (PDB ID: 1G81), UbiI (PDB ID: 4K22), UbiD (PDB ID: 5M1B) and UbiG (PDB ID: 4KDR) correspond to 
the proteins from E. coli and the 3D-structures of UbiX (PDB ID: 4RHE) and UbiA (PDB ID: 4TQ5) correspond 
to the proteins from Pseudomonas aeruginosa and Archaeoglobus fulgidus, respectively. The UbiJ 
monomer is colored grey and the UbiK dimer is colored green in the model of the E. coli UbiK–UbiJ 2:1 
heterotrimer complex 24. The oligomerization state of the 3D-models is indicated in brackets when it is 
greater than one. The ribbon diagrams were drawn using PyMOL (DeLano Scientific LLC).  
 
Following its prenylation, 4-HB is decarboxylated by the UbiD-UbiX system, which consists of the 
decarboxylase UbiD and its associated flavin prenyltransferase UbiX that produces the prenylated FMN 
(pFMN) used as a cofactor by UbiD 25. Recent studies have provided structural insights into the mechanism 
of both enzymes, detailing unusual chemistry in each case 26–28. Crystal structures of UbiD from E. coli in 
complex or not with pFMN have been solved, showing the quarternary structure as homohexamers 27. The 
3D-structure of UbiX from Pseudomonas aeruginosa is organized as a homododecamer 25. Interestingly, 
Blue Native-PAGE of E. coli’s soluble extracts showed a co-migration of UbiD and UbiX at ~700 kDa, 
7 
 
compatible with a UbiD6-UbiX12 complex (theoretical mass of 582 kDa) suggested by the individual 3D-
multimeric structures 29. 
Both O-methylation reactions in the biosynthesis of UQ8 are catalyzed by the S-adenosyl-L-
methionine (SAM)-dependent UbiG protein (Figure 1). Crystal structures of UbiG in complex with S-
adenosyl-L-homocysteine have been determined, with the proteins organized as monomers 30,31. 
Interestingly, the conserved region from amino acid 165 to 187 was identified in UbiG as essential for in 
vivo UQ production and for in vitro interaction with liposomes. The authors hypothesized that, upon 
interaction with membrane lipids, this region may promote the entrance of SAM into the protein 30,31. 
However, whether or not the membrane association of UbiG contributes to its catalytic activity has not 
yet been investigated. Moreover, UbiG purified from E. coli extracts exhibits in vitro methyltransferase 
activity 32 and a large part of UbiG is detected in the soluble fraction 29.  Thus, the relevance of the lipid 
binding region of UbiG remains unclear, especially when considering that UbiG is part of the soluble Ubi 
complex 29 (see 3.3). The C-methylation reaction of the pathway is catalyzed by UbiE, a SAM-dependent 
methyltransferase that is involved in the biosynthesis of UQ and MK 33. UbiE, for which no structural 
information is yet available, converts DDMQ8 to DMQ8 (2-octaprenyl-6-methoxy-1,4-benzoquinone to 2-
octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone, Figure 1) and demethyl-menaquinone to 
menaquinone 33.  
Finally, three related class A flavoprotein monooxygenases (FMOs) – UbiH, UbiI and UbiF - catalyze 
hydroxylation reactions on the aromatic ring at carbon atoms C-1, C-5, and C-6, respectively 34,35 (Figure 
1). These FMOs use dioxygen as a source of hydroxyl 36 and use the flavin adenine dinucleotide (FAD) to 
activate O2. UbiI and UbiH seem specific of the position that they modify, whereas UbiF has a broader 
regio-selectivity since it has a limited ability to hydroxylate C-5 in addition to C-6 35. The 3D-structure of a 
truncated form of UbiI revealed an association as a tetramer, with each monomer containing a typical FAD-
binding domain with a Rossman-like β/α/β-fold 35. It is important to note that in vitro assays have still not 
been developed for most Ubi enzymes, owing in part to the difficulty to obtain isolated purified proteins 
and to manipulate highly hydrophobic substrates.  
3.2 Accessory proteins in UQ biosynthesis  
Besides the enzymes discussed above, accessory proteins are also involved in UQ biosynthesis. 
UbiB is an important accessory factor given the nearly complete absence of UQ in E. coli mutants lacking 
a functional ubiB gene 37. UbiB was originally assigned to the C5-hydroxylation step 37, which is now known 
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to depend on UbiI 35. The UbiB family, composed of bacterial UbiB proteins and of the eukaryotic homologs 
Coq8-ACDK3/4, belongs to the atypical protein kinase-like family 38. Biochemical studies of Coq8 and 
ADCK3 showed that these proteins interact with UQ intermediates and possess ATPase activity but lack 
kinase activity in trans 38,39. Furthermore, the ATPase activity is stimulated by the interaction with 
membranes containing cardiolipin and by compounds that resemble UQ intermediates 40. Overall, UbiB 
family members were hypothesized to couple the hydrolysis of ATP to the extraction of UQ precursors out 
of the membrane in order to make them available for UQ biosynthetic enzymes 40, but this hypothetical 
role remains to be confirmed.   
Two other accessory factors, UbiJ and UbiK (formerly YigP and YqiC), were identified recently 24,41. 
Cells lacking ubiJ show a complete absence of UQ, while ubiK mutants retain ~ 20% UQ compared to wild-
type. The UQ deficiency is apparent only when the cells are grown in oxic conditions, suggesting that UbiJ 
and UbiK do not play important functions for UQ biosynthesis under anoxic conditions 24,41,42. Purified UbiJ 
and UbiK interact and form an elongated UbiJ1:UbiK2 complex 24 (Figure 1). UbiJ is able to bind UQ 
biosynthetic intermediates via its SCP2 domain (Sterol Carrier Protein 2), which crystal structure was 
solved recently 29. The current hypothesis is that UbiJ and UbiK assist several steps of UQ biosynthesis by 
presenting UQ intermediates to Ubi enzymes inside the Ubi complex (see 3.3) 29. In addition to producing 
a protein, the ubiJ locus was proposed to encode a small non-coding RNA (sRNA) termed EsrE 43,44. EsrE is 
composed of 252 nucleotides and resides in the 3’ half of the ubiJ gene 44. Our group showed that the C-
terminal part of the UbiJ protein is sufficient to maintain a minimal level of UQ biosynthesis and we 
provided evidence to rule out the implication of a sRNA 41. In contrast, another group reported that both 
the UbiJ protein and the sRNA EsrE are involved in UQ biosynthesis 44,45. While some controversy remains, 
data from both groups agree that the main contribution of the ubiJ locus to UQ biosynthesis is carried out 
by the UbiJ protein rather than by the sRNA EsrE 41,45.   
3.3 Supramolecular organization of the E. coli UQ biosynthetic pathway  
Since UbiA adds the polyprenyl tail onto 4-HB early on (Figure 1), most biosynthetic intermediates 
of the UQ pathway contain the octaprenyl tail and are therefore highly hydrophobic. Surprisingly, Ubi 
proteins acting downstream of UbiA are mostly soluble and the last six reactions of the pathway take place 
in soluble extracts, and not in the membrane fraction as the hydrophobicity of the biosynthetic 
intermediates would predict 29. In fact, we showed that a ~1 MDa Ubi complex composed of seven proteins 
(UbiE-K) exists in the soluble fraction of E. coli extracts 29. This complex contains the five enzymes (UbiE-I) 
that catalyze the reactions downstream of OHB (Figure 1) and the accessory factors UbiJ and UbiK, the 
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former being essential to the stability of the Ubi complex 29. We also demonstrated that the biosynthetic 
intermediates OPP and DMQ8 are bound in the Ubi complex and we proposed that the N-terminal SCP2 
domain of UbiJ mediates the interaction 29. Altogether, the current model is that the Ubi complex forms a 
soluble metabolon that synthesizes UQ from OHB (Figure 1). The trafficking of these two hydrophobic 
molecules between the membrane and the Ubi complex might involve the UbiB protein with its ATPase 
activity and its predicted C-terminal transmembrane domain 29,40.   
Interestingly, a similar organization of the UQ pathway has also been described in eukaryotes with 
complex Q (also termed the ‘CoQ-synthome’). Complex Q groups the enzymes of the late steps 10,46, but it 
is associated to the membrane, contrary to the Ubi complex which is soluble. Outstanding questions 
remain regarding the supramolecular assembly of the UQ pathway, notably the conservation of the Ubi 
complex in other bacterial species, the exact composition and stoichiometry of the complexes, their 3D 
structures, their potential dynamic nature and their cellular localization. A recent study started to address 
the two latter points in yeast 47.  
3.4 Discovery of a conserved O2-independent pathway  
Based on the observation that E. coli was able to synthesize UQ under anoxic conditions, the 
existence of a UQ biosynthesis pathway independent from O2 had long been hypothesized 48. This pathway 
remained uncharacterized until 2019, when we identified three genes, ubiT, ubiU and ubiV which are 
required for UQ biosynthesis under anoxic conditions but are dispensable under oxic conditions 42. The 
only reactions that differ between the O2-dependent and O2-independent pathways are the three 
hydroxylation steps catalyzed by the O2-consuming flavin hydroxylases UbiI, UbiH and UbiF 42. UbiU and 
UbiV, which belong to the U32 peptidase family, form a heterodimer that is required for the hydroxylation 
of DMQ8 in vivo. This result is in the line with the demonstration that UbiU from P. aeruginosa co-purifies 
with UQ8 and DMQ8 49 and we postulated that UbiU and UbiV may participate to the two other 
hydroxylation steps of the anaerobic UQ pathway 42,49. A role for UbiU and UbiV in O2-independent 
hydroxylation reactions is supported by recent studies showing that two other U32 peptidase family 
members - RlhA and TrhP – are required for the hydroxylation of C2501 on 23S rRNA 50 and of U34 on 
some tRNAs 51,52, respectively. The source of oxygen used in the hydroxylation reactions involving U32 
peptidase family members is unknown at this stage but prephenate, a metabolite of the shikimate 
pathway, is a candidate since it is required for the function of RlhA and TrhP 50,52. The presence of an iron-
sulfur cluster might be another feature common to U32 proteins. Indeed, we showed that UbiU and UbiV 
each carry a 4Fe-4S cluster ligated by a motif of conserved cysteine residues, which is found in most U32 
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peptidase family members 42. Interestingly, the function of RlhA and TrhP depends on these Cys residues 
and on the genes of the isc operon that catalyze the biogenesis of Fe-S clusters 50,52. Some additional 
players may also be involved in the function of UbiU and UbiV, like the low potential ferredoxin YhfL, which 
is required for the hydroxylation of tRNAs by TrhP 51. Overall, the U32 peptidase family emerges as a new 
class of O2-independent hydroxylases and additional work is required to elucidate the mechanism of these 
enzymes and the precise function of UbiU and UbiV in UQ biosynthesis.  
The role of UbiT in the O2-independent UQ biosynthetic pathway is still unclear. Yet, the presence 
of a SCP2 domain in the sequence of UbiT and the demonstration that UbiT binds the lipid phosphatidic 
acid 53 suggests that UbiT’s function is linked to lipids. Moreover, we recently showed that UbiT from P. 
aeruginosa binds UQ8 by recognizing its isoprenoid tail 49, suggesting that UbiT may perform a role similar 
to UbiJ in presenting the hydrophobic intermediates of the UQ pathway to Ubi enzymes. Interestingly, UbiJ 
is important for UQ biosynthesis only in oxic conditions, whereas the role of UbiT is limited to anoxic 
conditions 41,42. The possibility that UbiJ and UbiT may functionally replace each other depending on 
environmental conditions is an appealing hypothesis, given that both SCP2 proteins need to assist different 
sets of UQ biosynthetic enzymes, the O2-dependent hydroxylases (UbiI, UbiH, UbiF) in one case, and the 
O2-independent hydroxylases (likely UbiU and UbiV) in the other case.   
The ubiT, ubiU and ubiV genes are widespread in proteobacterial genomes that possess the O2-
dependent UQ pathway, suggesting that numerous bacteria have the previously unrecognized capacity to 
synthesize UQ over the entire O2 range 42. The low potential menaquinone (MK) is typically involved in 
transferring electrons in anaerobic respiratory chains, thus the physiological function(s) of UQ synthesized 
in anoxic conditions remains to be clarified in proteobacteria possessing both UQ and MK pathways. 
Several gram-negative bacteria, such as P. aeruginosa, contain UQ as sole quinone 2. We found that the 
ubiT, ubiU and ubiV genes are essential for UQ production by P. aeruginosa in anoxic conditions and that 
these genes are required for denitrification 49, a metabolism on which P. aeruginosa heavily relies to 
develop in the lungs of cystic fibrosis patients. Overall, the discovery of a widespread UQ pathway 
independent of O2 certainly changes our perspective of the relative contribution of various quinones to 
bacterial metabolisms in hypoxic and anoxic conditions. Interestingly, substantial amounts of UQ were 
reported lately in the anoxic zone of the water column of the Black Sea 5, suggesting that an O2-
independent pathway could have been at work in this ecosystem. It remains to be investigated whether 
or not bacteria containing ubiT, ubiU and ubiV genes are found in this ecological niche. By extension, 
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assessing the contribution of the O2-independent UQ pathway to anaerobiosis constitutes an exciting new 
research avenue. 
 
4) Variations in UQ biosynthesis pathways across bacteria 
 Our current view of the biosynthesis of UQ in bacteria is mostly based on the E. coli pathway 15. 
Even though numerous discoveries on E. coli are applicable to other bacterial species, recent studies using 
other bacterial models revealed an unsuspected diversity in the composition of the UQ biosynthesis 
pathway across bacteria.  
4.1 Synthesis of the aromatic ring precursor 
 So far, only 4-HB has been described as an aromatic ring precursor for UQ in bacteria. In contrast, 
eukaryotes are able to use additional molecules like para-aminobenzoic acid (pABA) 54,55. Note that pABA 
was shown to be processed through several steps of the UQ pathway in E. coli 55. However, the amino-
substituted intermediates were not converted into UQ 55, thus pABA is not considered a precursor for UQ 
in E. coli. The first gene identified to synthesize 4-HB for bacterial UQ biosynthesis was ubiC, which encodes 
a chorismate pyruvate-lyase 20. The xanB2 gene of Xanthomonas campestris was later shown to encode a 
chorismatase that produces 4-HB for UQ biosynthesis and 3-hydroxybenzoic acid for the biosynthesis of 
pigments from the xanthomonadin family 56. Even though UbiC and XanB2 use the same substrate –  
chorismate, the end product of the shikimate pathway – they do not share sequence or structural 
identities and belong to different protein families, chorismate pyruvate-lyase and chorismatase, 
respectively 56. xanB2 is present in several proteobacterial genera that do not contain ubiC 56, supporting 
a strong anti-occurrence of the two genes, although this has not been analyzed in details. It is currently 
unclear if all UQ producing bacteria contain UbiC or XanB2 or if additional unidentified 4-HB generating 
systems might also be involved in some species. Interestingly, a new subfamily of chorismatase (type IV) 
was shown to produce only 4-HB (and not a mixture of 3-HB and 4-HB as the type III chorismatase XanB2) 
57 and may therefore represent a new candidate to produce 4-HB for UQ biosynthesis.  
4.2 Hydroxylases  
 Three hydroxylation reactions on contiguous positions of the aromatic ring are required during 
the biosynthesis of UQ. The enzymes (UbiI, UbiH and UbiF) involved in the O2-dependent E. coli pathway 
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each hydroxylate one position and belong to the same family of flavin monooxygenases. An unrelated di-
iron monooxygenase Coq7 is implicated in the C-6 hydroxylation instead of UbiF in some bacterial species 
58–60. In 2016, a search for these four monooxygenases over representative proteobacterial genomes led 
to the identification of two new flavin monooxygenases, UbiL and UbiM 61. This study revealed an 
astonishing diversity of combinations of monooxygenases used by bacteria to synthesize UQ (19 
combinations in 67 species) 61. Interestingly, some genomes contained less than three UQ 
monooxygenases 61. We demonstrated that the UbiL protein from Rhodospirillum rubrum hydroxylates 
two positions (C-1 and C-5) and that the UbiM protein from Neisseria meningitidis hydroxylates three 
positions, rationalizing the presence of respectively two and one UQ monooxygenase genes in these 
species. Some genes are restricted to specific classes (ubiL to - and ubiF to -proteobacteria), while the 
distribution of ubiM across , , -proteobacteria is likely the result of horizontal gene transfer 61. 
Intriguingly, some species such as Xanthomonas campestris or Alteromonas macleodii contain four UQ 
monooxygenases 61. The reason as to why bacteria evolved such a diversity of O2-dependent UQ 
monooxygenases is still unknown. Of note, the putative hydroxylases of the O2-independent pathway 
show probably less diversity since a very high co-occurrence of UbiU and UbiV was observed 42.  
4.3 Incomplete UQ biosynthesis pathways  
The decarboxylation step of the pathway seems also variable. Indeed, the only enzyme implicated 
so far is the UbiD decarboxylase assisted by the prenyl-transferase UbiX 62. However, several authors 
recently noticed the absence of ubiX-ubiD genes from genomes containing most of the other ubi genes, 
suggesting that another enzymatic system could be involved in the decarboxylation reaction 60,63,64. A 
candidate gene ubiZ was proposed based on its co-localization with ubiE and ubiB in the genomes of 
Acinetobacter spp. and Psychrobacter sp. PRwf-1 64. The function of UbiZ remains to be investigated, but 
the fact that the ubiZ gene is not conserved in all the genomes lacking ubiD and ubiX suggests the existence 
of yet another decarboxylation system in UQ biosynthesis (Table 1).   
Another intriguing possibility is that incomplete quinone biosynthesis pathways might 
nevertheless be functional. Indeed, organisms with incomplete pathways might be able to scavenge 
particular metabolites from their environment rather than to synthesize them intracellularly. As such, 
genetic gaps in Wolbachia for the biosynthesis of 4-HB and of isopentenyl-pyrophosphate (one of the 
building blocks of the polyprenyl tail of UQ), led the authors to propose that these compounds might be 
acquired exogenously in order to support UQ biosynthesis 65. Remarkably, Streptococcus agalactiae 
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synthesizes its demethylmenaquinone thanks to a partial MK biosynthesis pathway and thanks to the 
uptake of the late intermediate 1,4-dihydroxy-2-naphthoic acid (DHNA) from the extracellular 
environment 66. Several Lactobacillus species also contain a partial MK pathway 64, suggesting that these 
bacteria might also rely on the import of exogenous intermediates to synthesize MK. Exchanges of 
metabolites between species are common in bacterial communities as in the gut of vertebrates, and small 
soluble components like DHNA are likely exchanged more easily than the large hydrophobic intermediates 
of the UQ pathway. Therefore, this strategy of complementing a partial pathway by importing extracellular 
intermediates is certainly more applicable to quinone pathways with a prenylation reaction occurring at a 
late stage (like the MK pathway in which most intermediates are small and hydrophilic 7) rather than to 
UQ and PQ pathways with early prenylation steps, and consequently large and hydrophobic intermediates.   
Overall, the large diversity of combination of enzymes used to synthesize UQ in various 
environmental conditions (Table 1) leads us to refer to UQ biosynthesis pathways and not anymore to a 
single pathway, as already proposed by Degli Esposti 63. We envision that even more UQ pathways will be 
revealed by systemic bioinformatic approaches aimed at studying the variations of UQ biosynthesis in the 
ever expanding diversity of bacterial genomes available. Let’s mention here that the task faces several 
difficulties, one of which is that only some ubi genes tend to group into operonic structures whereas others 
are dispersed around the chromosome 15.  
Table 1: Protein composition of the bacterial UQ biosynthetic pathways. italics: proteins involved only in 
the O2-independent pathway; underlined: proteins involved only in the O2-dependent pathway, ?:  
suspected existence of unidentified alternative proteins 
 
Step or function O2-dependent O2-independent
Synthesis of polyprenyl-
pyrophosphate
IspA, IspB IspA, IspB
Synthesis of 4-HB UbiC (chorismate lyase) UbiC XanB2 (chorismatase)
Polyprenyl transferase UbiA UbiA
Decarboxylation
UbiD (decarboxylase) 
UbiX (flavin 
prenyltransferase)
UbiD
UbiX UbiZ, ?
Methylation UbiG, UbiE UbiG, UbiE
Hydroxylation
UbiH, UbiF, UbiI
 (flavin cofactor) 
UbiU, UbiV 
(Fe-S cofactor)
UbiL, UbiM (flavin cofactor)
 Coq7 (di-iron cofactor)
SCP2 protein UbiJ UbiT
ATPase UbiB UbiB
Accessory factor  UbiK
E. coli pathways Alternative proteins in 
other bacteria
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5) An evolutionary perspective on (ubi)quinone biosynthetic pathways 
The rise of O2 concentrations on Earth caused a shift from globally reducing to oxidizing conditions 
around 2.4 billion years ago 67. This transition had far-reaching consequences, notably for quinones. 
Indeed, the low potential MK, which was present at the time of the great oxidation event, is readily 
oxidized by O2 68. Thus, it was proposed that microorganisms had to evolve higher potential quinones, like 
UQ and PQ, to sustain electron transport in bioenergetic chains operating under oxidizing conditions 68. 
This scenario is in line with the presence of O2-requiring steps, respectively three and one, in the 
biosynthetic pathways for UQ and PQ (Figure 2). However, our recent discovery of an O2-independent 
pathway for UQ production, widespread across proteobacterial lineages, suggests that UQ biosynthesis 
might have emerged in a less favorable O2 context than previously thought 42. One way to tackle the 
question of the relative origins of the quinone pathways is to study the evolution of the involved enzymes 
provided homologs are shared between pathways. 
 
 
 
 
 
   
Figure 2: Homology between bacterial UQ- and cyanobacterial PQ- pathways. A) Biosynthetic pathway of 
UQ in Escherichia coli with enzymes specific of the O2-dependent and O2-independent pathways in red and 
green respectively. B) Biosynthetic pathway of PQ in the cyanobacterium Synechocystis sp. PCC 6803. 
Reactions 1-3 in the UQ pathway and 1’-3’ in the PQ pathway are catalyzed by homologous enzymes. 
Proposed candidates for the PQ pathway (Slr1300? and Sll0418?) are homologous to UbiH and UbiG (see 
text). Enzymes with homologs in MK pathways are designated with (*). 
 
 5.1 Evolution of the UQ and PQ pathways 
It should be possible to address the relative appearance of the UQ and the PQ pathways since they 
share several homologs. Here, we consider only the cyanobacterial PQ pathway which consist of six 
reactions (Figure 2), as opposed to the pathway found in plant which is entirely different 69. In the 
15 
 
cyanobacterium Synechocystis sp., the first three steps of PQ biosynthesis involve homologs to UbiC, UbiA, 
and UbiD – UbiX of the UQ pathway: respectively, the chorismate lyase Sll1797, the 4-HB prenyltransferase 
Slr0926, and the decarboxylase - flavin prenyltransferase Sll0936 - Slr1099 70,71 (Figure 2). The following 
hydroxylation and methylation steps are still to be experimentally validated, but candidates have been 
proposed (Slr1300 and Sll0418) based on their homology to UbiH and UbiG enzymes of the UQ pathway 
72. Degli Esposti conducted a phylogenetic analysis of the UbiA, -C, -D, -H homologs and proposed that the 
UQ pathway derived from the PQ pathway and appeared twice independently in Alphaproteobacteria and 
in Zetaproteobacteria 63. Yet the trees built in this study are missing outgroups to root the phylogenies and 
as such do not definitively address the question of the relative origins of the UQ and PQ pathways 63.  
 
 5.2 Relationships between the UQ and the MK pathways 
Two pathways are known for the biosynthesis of MK 7: a fully characterized, long-known “classical MK 
pathway” and a still incomplete, more recently identified “futalosine pathway” 73. The classical MK 
pathway has only two steps in common with the UQ pathway: the prenylation step catalyzed by the 
prenyltransferase MenA (homologous to UbiA) and the methylation of the aromatic ring catalyzed by the 
literally shared enzyme MenG/UbiE. The characterized mqnA-E genes are specific to the futalosine 
pathway 74, but the still putative MqnP, MqnL, MqnM, and UbiE/MenG have homologs in the UQ pathway 
(UbiA, UbiD and UbiX, respectively) 64,73. These later mqnP, -L, -M genes were found to strictly co-occur 
with mqnA-E in many bacterial genomes, which reinforces their potential to participate in the futalosine 
pathway 64. In 2014, Zhi and colleagues observed that the futalosine pathway was found in more phyla of 
Bacteria and Archaea than the classical MK pathway 9. Furthermore, phylogenies of MenB, -C, -F suggested 
that the classical MK pathway was acquired in Archaea, specifically in Halobacteriaceae, as a result of 
lateral gene transfers from bacteria. In contrast, phylogenies for the MqnA, -D, and -C enzymes (specific 
to the futalosine pathway) globally retrieved the delineation of major bacterial and archaeal lineages, 
suggesting a vertical inheritance of the futalosine pathway and an early emergence predating that of the 
classical pathway 9.  
In 2016, Ravcheev and Thiele built phylogenies for genes of the two MK, and the UQ pathways 64. Their 
trees showed that homologs from the different pathways separated well (including those of the candidate 
MqnP, -L and –M, homologs of UQ enzymes). Interestingly, the only enzyme supposedly shared by the 
three pathways, the prenyltransferase UbiA/MenA/MqnP family, had a phylogeny displaying a dichotomy 
between the classical MK pathway on one side, and the futalosine and UQ pathways on another side 64. 
16 
 
However, in the tree of the methyltransferase family (UbiE/MenG), candidate enzymes of the futalosine 
pathway positioned within those of the classical MK pathway, and apart from those of the UQ pathway. 
The authors therefore suggested that the likely younger pathway of UQ evolved from parts of the two pre-
existing MK pathways, with some enzymes being more closely related to the futalosine pathway, and 
others to the classical pathway.  
Future studies in the context of recent discoveries, including that of new pathways (e.g. the O2-
independent UQ pathway) or new taxonomic groups of Archaea and Bacteria 75, are very likely to further 
enlighten the origins of quinones. Understanding the evolutionary relationships of the quinone pathways 
is indeed important as it bears strong implications for understanding the evolution of bioenergetics and 
adaptation to extant oxidizing environments.  
 
6) Conclusion and Perspectives  
Recent results have significantly expanded our view of the biosynthesis of UQ in bacteria. Several 
functional homologs have now been identified at various steps (Table 1) and a pathway independent from 
O2 has been characterized 42. The first proof of a supramolecular structuration of the E. coli O2-dependent 
UQ pathway was recently provided with the characterization of the Ubi complex 29. Whether such 
multiprotein complexes exist or not in other bacterial species and how they accommodate the variability 
of the constituting proteins (notably the hydroxylases) remains to be investigated. Understanding the 
regulation of the various UQ pathways and establishing their cellular localization will also be of interest. 
Indeed, we may expect the UQ biosynthesis apparatus to localize close to active bioenergetic enzymes, 
and some of them adopt a specific localization, as recently observed for the fumarate dehydrogenase and 
nitrate reductase in respiring E. coli 76. Whether the UQ pathways indeed originated from the MK pathways 
64 and how they evolved in the past 2 billion years is also a challenging and interesting question.  
To obtain a satisfactory understanding of the composition, regulation and evolution of the UQ 
pathways across bacteria, it will certainly be fruitful to combine biochemical and bioinformatic approaches 
in order to extract information from the multiple genomes now available in public databases. Besides 
increasing our basic knowledge of UQ pathways, such studies will also benefit bioengineering projects 
aimed at increasing the production of UQ 77 or that of related natural products like antroquinonol, a 
molecule currently in clinical trials for non-small-cell lung cancer 78. In addition, a better understanding of 
the UQ pathways may refine possible strategies to target them in order to develop novel antibiotics, and 
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may also provide valuable information to help pinpoint the nature of the bacterial ancestor of 
mitochondria 79. 
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